These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11895493)

  • 61. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
    J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
    [TBL] [Abstract][Full Text] [Related]  

  • 63. C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.
    Sharifah NA; Lee BR; Clarence-Ko CH; Tan GC; Shiran MS; Naqiyah I; Rohaizak M; Fuad I; Tamil AM
    Asian Pac J Cancer Prev; 2008; 9(4):663-70. PubMed ID: 19271345
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    World J Surg; 2008 Dec; 32(12):2675-80. PubMed ID: 18843437
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic factors of resectable intrahepatic cholangiocarcinoma.
    Chou FF; Sheen-Chen SM; Chen CL; Chen YS; Chen MC
    J Surg Oncol; 1995 May; 59(1):40-4. PubMed ID: 7745976
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma.
    Matsushima H; Kuroki T; Kitasato A; Adachi T; Tanaka T; Hirabaru M; Hirayama T; Kuroshima N; Hidaka M; Soyama A; Takatsuki M; Kinoshita N; Sano K; Nishida N; Eguchi S
    Dig Liver Dis; 2015 Dec; 47(12):1067-75. PubMed ID: 26341967
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.
    Aoba T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y; Nagino M
    Ann Surg; 2013 Apr; 257(4):718-25. PubMed ID: 23407295
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables.
    Okabayashi T; Yamamoto J; Kosuge T; Shimada K; Yamasaki S; Takayama T; Makuuchi M
    Cancer; 2001 Nov; 92(9):2374-83. PubMed ID: 11745293
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma.
    Yoh T; Hatano E; Seo S; Terajima H; Uchida Y; Taura K; Yasuchika K; Uemoto S
    J Hepatobiliary Pancreat Sci; 2018 Jun; 25(6):299-307. PubMed ID: 29656560
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
    Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ubiquitin-specific protease 14 expression associated with intrahepatic cholangiocarcinoma cell differentiation.
    Chuensumran U; Saelee P; Punyarit P; Wongkham S; Pairojkul C; Chauin S; Petmitr S
    Asian Pac J Cancer Prev; 2011; 12(3):775-9. PubMed ID: 21627382
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of mass-forming intrahepatic cholangiocarcinoma with viral hepatitis.
    Horino K; Beppu T; Komori H; Masuda T; Hayashi H; Okabe H; Takamori H; Baba H
    Hepatogastroenterology; 2012 Jun; 59(116):1217-9. PubMed ID: 22580675
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.
    Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Shuto T; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2003; 50(52):1069-72. PubMed ID: 12845984
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma.
    Lee CT; Wu TT; Lohse CM; Zhang L
    Hum Pathol; 2014 Nov; 45(11):2334-40. PubMed ID: 25245603
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.
    Camp RL; Rimm EB; Rimm DL
    Cancer; 1999 Dec; 86(11):2259-65. PubMed ID: 10590366
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
    Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
    Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe.
    Okami J; Dono K; Sakon M; Tsujie M; Hayashi N; Fujiwara Y; Nagano H; Umeshita K; Nakamori S; Monden M
    J Gastrointest Surg; 2003 Nov; 7(7):850-6. PubMed ID: 14592657
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma.
    Sirica AE
    World J Gastroenterol; 2008 Dec; 14(46):7033-58. PubMed ID: 19084911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.